Late-Onset Treatment Study Extension Protocol

Clinical trial NCT00455195 · COMPLETED

Trial details

NCT number: NCT00455195
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pompe Disease (Late-Onset)Glycogen Storage Disease Type II (GSD-II)Glycogenesis Type II Acid Maltase Deficiency (AMD)

Start date: 2007-03-01
Primary completion: 2008-10-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.